Prostatis Group’s FT Vest US Equity Enhance & Moderate Buffer ETF December XDEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,229
Closed -$229K 174
2025
Q1
$229K Sell
6,229
-1,554
-20% -$58.2K 0.07% 138
2024
Q4
$290K Sell
7,783
-1,367
-15% -$50.7K 0.08% 130
2024
Q3
$336K Sell
9,150
-1,288
-12% -$46.8K 0.11% 107
2024
Q2
$377K Sell
10,438
-147
-1% -$5.22K 0.13% 108
2024
Q1
$373K Sell
10,585
-114,626
-92% -$3.98M 0.14% 106
2023
Q4
$4.26M Sell
125,211
-15,995
-11% -$536K 1.78% 14
2023
Q3
$4.63M Sell
141,206
-4,600,042
-97% -$151M 2.26% 11
2023
Q2
$4.87M Buy
4,741,248
+4,587,052
+2,975% +$146M 2.27% 12
2023
Q1
$4.82M Sell
154,196
-5,523
-3% -$169K 2.54% 12
2022
Q4
$4.75M Buy
+159,719
New +$4.65M 2.9% 7

Other funds holding XDEC

Prostatis Group's XDEC Position: Q2 2025 in Review

Prostatis Group sold out of FT Vest US Equity Enhance & Moderate Buffer ETF December (XDEC) in Q2 2025, closing a stake of 6,229 shares — an estimated $229K sold.

Prostatis Group first reported a position in XDEC in Q4 2022 and held it in 10 quarters. The position peaked at $4.87M in Q2 2023. 87 funds tracked by Wall St. Rank hold XDEC as of Q2 2025.

  • Prostatis Group reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF December position as of Q2 2025 after selling out during the quarter.
  • Prostatis Group sold 6,229 FT Vest US Equity Enhance & Moderate Buffer ETF December shares in Q2 2025, an estimated $229K.
  • Prostatis Group first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF December in Q4 2022 and held it in 10 quarters.
  • Prostatis Group's FT Vest US Equity Enhance & Moderate Buffer ETF December position peaked at $4.87M in Q2 2023.
  • 87 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF December as of Q2 2025.

Based on Prostatis Group's 13F filing for Q2 2025, filed 25 Jul 2025.